StonvexLoading…
StonvexStonvexStonvexCore line items from WSO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.24B | $7.62B | $7.28B | $7.27B |
Operating Income | $720.35M | $781.77M | $794.81M | $831.58M |
Net Income | $496.99M | $536.29M | $536.34M | $601.17M |
EPS (Diluted) | $12.25 | $13.30 | $13.67 | $15.41 |
Total Assets | $4.41B | $4.48B | $3.73B | $3.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $433.28M | $526.27M | $210.11M | $147.50M |
Free Cash Flow OCF − CapEx | $535.06M | $743.01M | $526.48M | $536.31M |
Shares Outstanding | 37.90M | 37.51M | 36.53M | Not available |